Ending the Ebola Virus Scourge A Case for Natural Products
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2016, Vol 1, Issue 1
Abstract
We investigated the binding affinities of antiviral of ethno medicinal origin to five Ebola viral proteins by in silico molecular docking simulations. One hundred and seventy three compounds were obtained from literature, extracted from ZINC® database as mol2 files and further prepared for docking simulations using Auto Dock tools v. 1.5.6. Five Ebola drug targets (VP24, VP30, VP35, VP40 and NP) were obtained as pdb files from the Protein Data Bank and further prepared for docking simulations using both Chimera v. 1.8.1 and Auto Dock tools v. 1.5.6. Virtual screening and docking simulation experiments were performed using AutoDockVina 4.0 on a Linux platform. Docking results were analyzed using PyMol v.0.99r c6. At least five compounds (robustaflavone, cepharanthine, corilagin, hypericin and theaflavin) were identified as frontrunner antivirals with concurrent binding affinities on the five tested Ebola viral proteins. Binding free energies ranging between -6.225 to -8.675kcal/mol were obtained for the compounds. Compounds are recommended as experimental antivirals of ethno medicinal origin with possible anti-Ebola activities. In vitro and clinical trial investigations into the anti-Ebola activities of these compounds are recommended.
Authors and Affiliations
Uzochukwu IC*, Olubiyi OO, Ezebuo FC, Obinwa IC, Ajaegbu EE, Eze PM, Orji CE, Onuoha MC, Ejiofor II and Ikegbunam MN
Keywords
Related Articles
- EP ID EP745751
- DOI 10.23880/oajpr-16000105
- Views 1
- Downloads 0
Medication Errors
These results relied on data voluntary provided to American Hospital Association. It is likely that substantial number of medication errors go undetected or unreported to the hospital medication error reporting system.
C-termini Analysis of Monoclonal Antibody Fragmentation
Fragmentation of therapeutic monoclonal antibodies (mAbs) is a critical quality attribute (CQA) that needs to be monitored and controlled during the biopharmaceutical drug development. Fragmentation of a protein is a res...
Detonation Nanodiamonds: Opportunity for Pharmaceutical and Medical Application
Detonation nanodiamonds have 4-5 nm size primary particles, stable inert core, high surface area and tunable surface structures. They are very attractive from pharmaceutical point of view as a drug delivery vehicle. Nitr...
Transdermal Delivery Offer for Low Dose Acetylsalicylic Acid
The use of Acetyl Salicylic Acid (ASA) in the secondary prevention of cardio vascular diseases is well known. Orally administered ASA is rapidly metabolized to its principal metabolite Salicylic Acid (SA) in the gastroin...
Diclofenac Sodium Loaded Nanosized Ethosomes: An Investigation on Z-Average, Polydispersity and Stability
Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID). Oral therapy with NSAID is always associated with several side effects such as gastric bleeding, and ulceration. The purpose of this work was to explor...